...
Contact Now

GPC3 CAR-T

GPC3 CAR-T Therapy

Glypican-3 (GPC3) is a special protein found mostly on the surface of liver cancer cells, making it a very good target for treatments. Liver cancer is a serious disease where cancer cells grow quickly and can spread. GPC3 CAR-T therapy uses the patient’s own immune T cells, which are changed in the lab to recognize GPC3 and attack liver cancer cells.

This therapy helps the immune system find and kill liver cancer cells more effectively, protecting healthy cells while focusing on the tumors.

GPC3 CAR-T Therapy is used for

  • Liver Cancer

How GPC3 CAR-T Therapy works

  • Doctors take T cells from the patient’s blood
  • In the lab, these T cells are changed to carry a special receptor (CAR) that finds GPC3 on liver cancer cells
  • The modified CAR-T cells are given back to the patient
  • These CAR-T cells seek out and destroy liver cancer cells with GPC3
  • This helps shrink tumors and slows cancer growth

Advantages of GPC3 CAR-T Therapy

  • Targets liver cancer cells specifically, avoiding damage to healthy liver tissue
  • Shows very promising results with about 76% of patients responding well
  • Helps patients with hard-to-treat liver cancer
  • Uses the body's own immune system to fight cancer safely
  • Offers a new hope for better liver cancer treatment

Our Advantages

  • Advanced Technology: Immuno Vector uses the latest techniques to create safe and powerful GPC3 CAR-T cells
  • Proven Results: Our therapy has shown high response rates in clinical studies
  • Personalized Care: We offer tailored treatments to match each patient's unique condition
  • Safety Focused: We prioritize minimizing side effects and keeping patients safe
  • Full Support: Immuno Vector is committed to supporting patients throughout their treatment journey
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.